impax – HedgeChatter

2 Biotech Stocks Deutsche Bank Just Initiated – Sagent … – Benzinga

Related SGNT5 NASDAQ Healthcare Stocks With The Highest EPS Growth Forecast For Next 5 YearsPorat To Google Just One Of The Week’s Top Management Changes; Here Are 7 MoreRelated IPXLFTC Requires Divestitures in Connection With Impax Laboratories Inc.’s Proposed Acquisition of CorePharma, LLCJPM Securities Picks Through Biotech News For WinnersMylan makes $205/share bid for Perrigo; Generic firms rally(Seeking Alpha)Shares of […]

2 Biotech Stocks Deutsche Bank Just Initiated

Shares of Sagent Pharmaceuticals Inc (NASDAQ: SGNT) and Impax Laboratories Inc (NASDAQ: IPXL) were up on Wednesday, after analysts at Deutsche Bank initiated coverage on Tuesday.
Sagent Pharmaceuticals
The analysts initiated coverage of Sagent with a Buy rating and a $29 price target. They say they have always liked the biotech company’s “focus on the attractive generic injectables segment but now believe […]